Paul Edgecliffe-Johnson
Analyst · Morgan Stanley
Thank you, Richard, and good morning, everyone. I'll start by giving you a bit more color on our quarterly trading performance by region.
In the Americas, RevPAR grew 6.6% with 6.4% in the U.S., with increases in both rate and occupancy. This is driven by mid-single-digit growth in both transient and group business, helped by the better economic environment and improved business confidence. Government demand continued to be down year-on-year but showed sequential improvement through the quarter after the signing of the spending bill in mid-January. All of our brands in the U.S. drove mid- to high single-digit RevPAR growth, led by Crowne Plaza, up 7.8%; and our extended-stay brands, Staybridge Suites and Candlewood Suites, both up over 8%. Crowne Plaza outperformed its segment on a total RevPAR basis by more than 200 basis points in the quarter. This was driven by better occupancy, particularly from groups, which drove almost 40% for the brand's demand growth, which -- most of which was on weekdays. This demonstrates the ongoing benefits we are seeing from the brand's repositioning program.
Staybridge Suites and Candlewood Suites both delivered mid-single-digit occupancy growth in the quarter, driving sustained benefits from a program of extensive hotel refurbishments carried out mostly during 2012.
Holiday Inn had a strong quarter with RevPAR up 6.4%, driven by solid improvement in group business in both February and March. As expected, trading in March was helped by the soft Q2 comparative from last year. The Holiday Inn brand family continues to hold a significant $4.50 RevPAR premium to its industry segment. This demonstrates the extensive brand relaunch that has taken place, which has included the removal of over 1,500 substandard hotels and the additions of almost 2,100 new ones.
The U.S. continues to benefit from a favorable supply-and-demand dynamic, and room nights sold have now beaten monthly records for each of the last 37 months. Occupancy for our hotels in the U.S. is over 130 basis points above the prior peak and is over the 70% level for our InterContinental, Hotel Indigo and extended-stay brands.
Despite the improving financing environment, industry forecasters only expect U.S. supply growth of around 1% this year and expect it to remain below the historic 2% average for the foreseeable future. However, when supply growth does come back, which will be positive for IHG, we have 13% of the active hotel pipeline compared to 5% of industry rooms, so we will continue to take share as these rooms open.
RevPAR was up 6.1% in Europe, driven by good gains in both rate and occupancy. Occupancy is now less than 200 basis points below its prior peak. But in real terms, RevPAR still has some way to recover.
11.6% RevPAR growth in the U.K., our largest market in Europe, reflects double-digit growth in both London and the regions. U.K. occupancy levels are now at 70%, our highest first quarter since 2007, reflecting the better macroeconomic conditions across the country and strong demand for IHG's brands.
In Germany, RevPAR growth of 5.1% was driven by increased trade fair activity, specifically in Düsseldorf and Frankfurt, which, together, contribute more than 1/4 of IHG's total revenues in the country.
France saw RevPAR down 4.4% with declines in both the provinces and in Paris, in line with the industry. Our InterContinental Paris Le Grand Hotel was disrupted by planned renovation work, which we expect to be completed during the second quarter.
We've also seen encouraging performance outside of these key European markets with mid-single-digit growth in Netherlands and Switzerland and some occupancy-led RevPAR improvements in Southern Europe.
Asia, Middle East and Africa is our most diverse region, with different dynamics driving each of our key markets. RevPARs for the region was up 7.1% if you exclude Thailand, Egypt and the Lebanon, where political unrest continues to have a negative impact on the overall numbers. Even when these markets are included, RevPAR in the region still grew almost 4%. Our performance was led by Southeast Asia, excluding Thailand; and Japan with both markets driving double-digit RevPAR growth.
Southeast Asia is benefiting from strong demand in developing markets such as Indonesia, where pre-election spending has driven increased demand, and Vietnam, where our hotels in Hanoi, in particular, have successfully grown business from large multinationals. Japan's continued strong growth was driven by both rate and occupancy and reflects the ongoing positive economic environment.
High single-digit RevPAR growth in Australia was driven by strength in Adelaide and Melbourne and also in Sydney, where our InterContinental Hotel hosted the G20 finance ministers' meeting in February.
In the Middle East, our overall performance is a mix of solid trading in our 2 largest markets of the United Arab Emirates and Saudi Arabia, offset by the declines in Egypt and in Lebanon.
Greater China RevPAR grew 3.9%, with IHG's scale, expertise and breadth of brands continuing to drive significant outperformance against the industry. Trading in the region was led by good RevPAR growth in Tier 1 cities and resorts with increased demand from leisure guests over the Chinese New Year period. The region does continue to experience an industry-wide reduction in spend on conferences and meetings. IHG is not reliant on any one segment, though, driving solid growth in nongovernment-related corporate business in the quarter.
In addition, transient business has continued the good growth levels from 2013, and our Holiday Inn Express brand drove RevPAR up almost 8%.
As Richard mentioned earlier, in March, we completed the disposal of InterContinental Mark Hopkins San Francisco and an 80% interest in InterContinental New York Barclay, with gross proceeds totaling $394 million. Both deals were structured with long-term management contracts, which will retain the InterContinental brand on these hotels for decades to come. The Barclay will close soon for its previously announced $175 million refurbishment program, 20% of which IHG will fund, in line with our share of the joint venture.
Following these deals, we now have just 7 owned hotels open, to which we will add 3 when we open the EVEN Hotels, which are currently in the pipeline. Given the strength of global demand for prime hotel markets and as a further step towards continuing to reduce the capital intensity of the business, we are now reviewing opportunities for further asset sales, so we'll let you know any updates as our plans develop.
The $750 million special dividend we announced today reflects not just the completion of these asset sales and the robust free cash flow generated by our fee-based model, but also our strategy to have an efficient balance sheet whilst maintaining an investment grade credit rating. Being investment grade is important to us and to the owners, who signed 20-plus-year contracts under our brand. The best proxy for this is around 2x to 2.5x net debt-to-EBITDA. That is where we feel comfortable. And in strong trading conditions, where the outlook is positive, our intention is to run towards the top end of this range.
The special dividends announced today will take total funds returned to shareholders since 2003 to $10.3 billion, including $1.6 billion in ordinary dividends. This reinforces our clear, consistent capital allocation strategy, which has meant that, on top of the ordinary dividend, we have returned additional funds to shareholders in 8 of the 11 years IHG has been operating as a standalone company.
Going forward, we will continue to yield additional return to shareholders based on further asset sales and the significant amount of cash that IHG's model generates.
Looking ahead, current trading trends give us confidence for the rest of the year. Forward bookings remain encouraging, with increases in both rates and rooms on the books. We expect our signing and openings pace to remain strong, and we are very excited by the prospect of the first hotels for our new brand opening -- for our new brands opening, EVEN by the end of June and HUALUXE by the end of the year.
And with that, Richard and I will take your questions. Thank you.